News

We are pleased to announce that the new Seegene NovaplexTM Dermatophyte Assay is now available.

Quantum Blue® Infliximab and Quantum Blue® Adalimumab offer quantification of infliximab and adalimumab originator drugs, as well as their biosimilars, allowing for identification of patients with suboptimal drug levels as part of their therapeutic drug monitoring.

We are happy to announce the new Novaplex™ SARS-CoV-2 Variant VII Assay from Seegene, which will become available by the end of December 2021.